Glenbrook Capital Management Acquires 5,685 Shares of Senestech (NASDAQ:SNES) Stock

Senestech, Inc. (NASDAQ:SNES) major shareholder Glenbrook Capital Management purchased 5,685 shares of the firm’s stock in a transaction that occurred on Wednesday, February 4th. The shares were acquired at an average price of $1.82 per share, with a total value of $10,346.70. Following the purchase, the insider owned 599,470 shares in the company, valued at $1,091,035.40. This trade represents a 0.96% increase in their ownership of the stock. The acquisition was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Major shareholders that own at least 10% of a company’s shares are required to disclose their sales and purchases with the SEC.

Glenbrook Capital Management also recently made the following trade(s):

• On Thursday, February 5th, Glenbrook Capital Management bought 2,884 shares of Senestech stock. The stock was acquired at an average cost of $1.77 per share, with a total value of $5,104.68.
• On Monday, February 2nd, Glenbrook Capital Management bought 42,739 shares of Senestech stock. The shares were acquired at an average price of $1.98 per share, with a total value of $84,623.22.
• On Friday, January 30th, Glenbrook Capital Management acquired 5,399 shares of Senestech stock. The shares were bought at an average cost of $1.87 per share, with a total value of $10,096.13.

Senestech Stock Performance

Shares of SNES stock traded up $0.09 during midday trading on Friday, hitting $1.87. The company had a trading volume of 47,931 shares, compared to its average volume of 44,761. The stock has a market cap of $9.76 million, a price-to-earnings ratio of -0.51 and a beta of 0.21. The company has a debt-to-equity ratio of 0.01, a current ratio of 15.75 and a quick ratio of 14.73. The company’s 50 day simple moving average is $2.29 and its 200 day simple moving average is $3.57. Senestech, Inc. has a 52-week low of $1.30 and a 52-week high of $6.24.

Senestech (NASDAQ:SNES) last released its quarterly earnings results on Monday, November 10th. The company reported ($0.28) EPS for the quarter, topping the consensus estimate of ($0.35) by $0.07. The business had revenue of $0.69 million during the quarter, compared to analysts’ expectations of $0.73 million. Senestech had a negative return on equity of 98.35% and a negative net margin of 253.54%. Research analysts anticipate that Senestech, Inc. will post -10.22 earnings per share for the current fiscal year.

Institutional Investors Weigh In On Senestech

Several institutional investors and hedge funds have recently made changes to their positions in SNES. Sabby Management LLC purchased a new position in Senestech during the 3rd quarter valued at about $313,000. Corsair Capital Management L.P. purchased a new stake in shares of Senestech in the second quarter valued at $255,000. Jane Street Group LLC acquired a new stake in shares of Senestech during the second quarter valued at $161,000. Millennium Management LLC purchased a new stake in Senestech during the 3rd quarter worth about $126,000. Finally, Essex Investment Management Co. LLC acquired a new position in Senestech in the 3rd quarter valued at about $115,000. 5.19% of the stock is currently owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

Separately, Weiss Ratings restated a “sell (e+)” rating on shares of Senestech in a research note on Monday, December 29th. One analyst has rated the stock with a Strong Buy rating, one has assigned a Hold rating and one has assigned a Sell rating to the company. Based on data from MarketBeat, Senestech presently has an average rating of “Hold”.

About Senestech

SenesTech, Inc (NASDAQ: SNES) is a biotechnology company specializing in non-lethal pest management solutions. The company’s core focus is the development and commercialization of fertility-based control methods for commensal rodents, providing an alternative to traditional rodenticides. By targeting the reproductive cycle of rats, SenesTech aims to reduce rodent populations over time without the use of toxic chemicals, offering a more sustainable approach for pest management professionals.

The company’s flagship product, ContraPest®, is an EPA-registered liquid bait that disrupts rodent reproduction.